Andy Seaman (he/they) is an Associate Professor of Medicine at Oregon Health & Science University, the Medical Director of Hepatitis and HIV Services at Portland, Oregon’s Central City Concern, and the Director of Substance Use Disorder Services at Better Life Partners, a harm reduction-based opioid use disorder treatment program. He is boarded in internal medicine and addiction medicine. He is a harm reductionist, educator, researcher, and activist for substance decriminalization, overdose prevention sites, and the rights of people who use drugs. His research centers on the intersection of hepatitis C and injection drug use and the implementation of harm reduction into health systems.

Andy has the following disclosure:

I have received investigator-initiated research support from Merck, Abbvie, and Gilead FOCUS Foundation